The Frederick News-Post
by Heather Mongilio
April 8, 2019
A Frederick National Laboratory for Cancer Research-founded organization has announced plans to partner with a California-based technology company to advance its artificial intelligence drug discovery program.
Accelerating Therapeutics for Opportunities in Medicine (ATOM), based in San Francisco, aims to make the drug discovery process quicker and more patient-centric, according to a press release from the company...
